Your Health Summary (YHS), a patient-data sharing system for New Zealand’s health professionals, now holds the records of 450,000 individuals. Launched in April 2020, the records are currently
CooperVision’s Dreamlite ortho-k contact lenses for slowing myopia in children have met European Union approval criteria, earning them a CE mark. Currently only available in Europe, the Middle East
Chicago-based fashion and lifestyle blogger Whitney Buha ended up with ptosis after a routine Botox visit. Buha, author of the blog Something Whitty, said she was embarrassed about the way she looked but felt compelled to share pictures online as she didn’t know ptosis was a possible side effect of
A review of studies whose data indicate a gut-eye axis – where the intestine’s microbiome influences eye health – has stated that a specific diet, in some cases including pre- and probiotics, could
A Thai study to evaluate the bacterial adherence properties of soft contact lenses (CLs) found that HEMA lenses are most suitable for biofilm formation, while hydrogel-based CLs are less supportive of
Innovega’s eMacula system, pairing smart contact lenses (CLs) with display eyewear, has demonstrated positive results with partially sighted people going about their daily tasks, including reading,
In 1976, Robert Randall took on the United States government and won. Diagnosed with glaucoma and having tried conventional medication, the only treatment that offered him relief was cannabis. Fighting for the right to legally use his medication, the Superior Court of the District of Columbia sided
A study by the Icahn School of Medicine at Mount Sinai in the US is the first to show how caffeine and a patient’s genetic disposition increases the risk
A mobile app developed for patient remote vision monitoring affords patients and practitioners an added level of protection, particularly during long intervals between treatments and at the end of a
The majority of New Zealand employers (56%) and employees (59%) have felt stressed about Covid-19 in the past six months, with Kiwis under the age of 25 reporting the highest stress levels (73%), a new report has revealed.
Miami-based Heru, a Bascom Palmer Eye Institute spinoff, has secured US$30 million series A financing to advance its artificial intelligence (AI)-powered eye diagnostic and vision-correction technology platform.
Visus Therapeutics has received FDA approval to begin clinical development of Brimochol, its presbyopia-correcting eye drop. A combination of the FDA-approved drugs carbachol (which reduces pupil size) and brimonidine (which sustains that effect while diminishing side effects), Brimochol is designed